The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be
| Study Name on ClinicalTrials.gov (link is external) |
Registered: https://www.isrctn.com/ISRCTN27664426 Detection of respiratory exacerbations in adults with cystic fibrosis using artificial intelligence |
|---|---|
| Study Drug | Not applicable |
| Type of Study Drug | Not applicable |
| Study Title | Detection of respiratory exacerbations in adults with cystic fibrosis using artificial intelligence |
| Study Phase | Not applicable |
| Study Sponsor | Papworth Hospital NHS Foundation Trust (UK) |
| Participating ECFS-CTN sites | Please contact ecfs-ctn@uzleuven.be for most recent sitelist |
| Age | Adult patients |